Hester Biosciences has informed that the Board of Directors of the Company at its meeting held on June 29, 2016, has decided to obtain enabling approvals, from the shareholders for issuance of equity shares, and/or equity linked securities and/or securities convertible into equity shares through Qualified Institutional Placement (QIP) or preferential allotment for an amount not exceeding Rs 75 crore. Further members approval shall be obtained in forthcoming Annual General Meeting for this matter.
The above information is a part of company’s filings submitted to BSE.
